CPhI 2025: Functional Excipients in Frankfurt, Germany

Ingredientpharm is excited to participate in CPhI 2025, the leading global pharmaceutical exhibition, from October 28–30, 2025, in Frankfurt, Germany, at booth 5.1D75. As a trusted supplier in pharmaceutical ingredients, we focus on improving the quality and performance of excipients and API granulation. This year, we will present our latest solutions: pharmaceutical pellets and granulated Ibuprofen DC100.

3 key messages:

  • Meet Us at CPhI 2025 (Booth 5.1D75, Frankfurt, Oct 28–30)

    Join us as we showcase our latest advances in functional excipients and granulation solutions, designed to improve efficiency, quality, and patient outcomes.

  • Pharmaceutical Pellets (CELLETS® & TAP®)

    Built on precision and consistency, our high-quality starter beads not only support modern manufacturing but also enable modified-release formulations — leading to better drug performance and improved patient compliance.

  • Granulated Ibuprofen DC100

    With its 100% API direct compression grade, Ibuprofen DC100 removes unnecessary excipients and streamlines production. As a result, manufacturers can simplify processes, cut costs, and deliver reliable, high-performing pain-relief medicines.

CPhI 2025: Discover functional excipients & pharma innovations

Pharmaceutical Pellets: Designed for Better Formulations

At ingredientpharm, we prioritize precision and consistency in pharmaceutical manufacturing. Our pharmaceutical pellets meet strict quality standards while supporting modern drug formulations. Consequently, they provide superior options for modified-release profiles, improving medication effectiveness and patient compliance.

We use advanced pelletization technology to ensure uniformity in every batch. This approach gives manufacturers reliable ingredients for safe and effective medicines. You can choose between inert MCC pellets (CELLETS®) or functional starter beads (TAP®).

Granulated Ibuprofen DC100: Streamlining Pain Management

We also introduce granulated Ibuprofen DC100, a direct compression grade that simplifies tablet production. By eliminating complex processing steps, it reduces production time and costs. Ibuprofen DC100 contains 100% API, so manufacturers do not need additional excipients.

Moreover, this product delivers excellent flowability, compressibility, and dissolution. Therefore, it is ideal for optimizing NSAID formulations. With Ibuprofen DC100, ingredientpharm helps manufacturers produce reliable and effective pain-relief medicines.

Visit Ingredientpharm at CPhI 2025

We invite you to visit booth 5.1D75 at CPhI 2025 to learn more about our pharmaceutical pellets and granulated Ibuprofen DC100. Our experts will explain how these products can improve formulation efficiency, reduce production steps, and benefit patients.

Join us to explore the future of pharmaceutical ingredients and discover why ingredientpharm remains a trusted partner in the industry. We look forward to meeting you at CPhI 2025 in Germany.